Cash Flow Statement

Acquisitions Amortization Amortization Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Cellebrite DI (CLBT) Other financing activities (2021 - 2024)

Cellebrite DI's Other financing activities history spans 3 years, with the latest figure at -$11000.0 for Q3 2024.

Quarterly Other financing activities changed N/A to -$11000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was -$11000.0 through Dec 2024, up 99.94% year-over-year, with the annual reading at -$11000.0 for FY2024, 96.81% up from the prior year.
Other financing activities came in at -$11000.0 for Q3 2024, up from -$345000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $29.3 million in Q3 2021 to a low of -$17.5 million in Q4 2021.
The 3-year median for Other financing activities is -$178000.0 (2023), against an average of $2.9 million.